Akers Bio

Akers Biosciences (AKR)

Company name:Akers Bio
EPIC:AKR (delisted)Trading Currency:GBX
Market Sector:AIMPISIN:
Market Segment:ASX1Share Type:DE
WWW Address:http://www.akersbiosciences.com/Description:COM SHS NPV
Industry Sector:HEALTH CARE EQUIPMENT & SERVICES
 Price Price Change [%] Bid Offer Open High Low Volume
 57.50 uk.advfn.com/p.php?gfx=/gb/dot 0.0 [0.00] 50.00 65.00 - - - -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 7.17 12.48 -0.17 -47.58 - - - -

Akers Biosciences Key Figures

(at previous day's close)
Market Cap.7.17m
Shares In Issue12.48m
Prev. Close57.50
PE Ratio- 
Dividend Yield-%
EPS - basic-47.58p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-30.15p
Return On Equity (ROE)-63.70%
Operating Margin-147.74%
PEG Factor- 
EPS Growth Rate-%
Dividends PS Growth Rate-%
Net Debt0.99m
Gross Gearing16.29%
Quick Assets5.63m
Net Working Capital5.68m
Intangibles / Fixed Assets78.42%
Turnover PS23.32p
Pre-Tax Profit PS-34.45p
Retained Profit PS-34.45p
Cash PS2.60p
Net Cash PS-7.92p
Net Tangible Asset Value PS *47.38p
Net Asset Value PS54.09p
Spread15.00 (23.08%) 

Akers Biosciences Balance Sheet

LSE:AKR:Liabilities+EQLSE:AKR:Assets

Share Price Performance

Sorry No Data Available

Share Price Chart (5 years)

Akers Biosciences Historic Returns

Sorry No Data Available

Akers Biosciences Key Management Ratios

Akers Biosciences Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 0.90 
Tobin's Q Ratio (excl. intangibles)1.06 
Dividend Yield-%
Market-to-Book Ratio1.06 
Price-to-Pre-Tax Profit PS-1.67 
Price-to-Retained Profit PS-1.67 
Price-to-Cash Flow PS-1.91 
Price-to-Sales PS2.47 
Price-to-Net Tangible Asset Value PS1.21 
Price-to-Cash PS22.10 
Net Working Capital PS45.53 
Price Pct to Working Capital PS1.26%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Akers Biosciences Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing12.26%
Net Gearing (excl. Intangibles)13.68%
Gross Gearing16.29%
Gross Gearing (excl. Intangibles)18.17%
Gearing Under 1 Year16.29%
Gearing Under 1 Year (excl. Intgbl)18.17%
Assets/Equity1.19 
Cash/Equity4.81 
(Liquidity Ratios)
Net Working Capital to Total Assets70.47%
Current Ratio5.33 
Quick Ratio (Acid Test)4.29 
Liquidity Ratio0.25 
Cash & Equiv/Current Assets4.64%
(Solvency Ratios)
Enterprise Value6.85m
CFO/Sales-1.29 
CFO/Attributable Profit- 
CFO/Assets-0.47 
CFO/Debt-2.87 
Total Debt/Equity Market Value0.18 
Total Debt/Sales0.45 
Total Debt/Pre-Tax Profit-0.31 
Total Debt1.31m
Total Debt/Net Current Assets0.23%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-30.41%
5 yr Compound Earnings Growth-8.67%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs5 
Beta (60-Mnth)Beta (36-Mnth)
-0.1715-0.2093

Akers Biosciences Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-63.70%
Return On Assets (ROA)-53.82%
Net Profit Margin-147.74%
Assets Turnover0.36 
Return On Equity (ROE)-63.70%
Return On Investment (ROI)-68.76%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-147.74%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.47 
Fixed Assets Turnover1.90 
Current Assets Turnover0.45 
Net Working Capital Turnover 
Inventory Turnover1.50 
(Other Operating Ratios)
Total Assets-to-Sales2.74 
Debtors-to-Sales59.25%
Debt Collection Period216.26Days

Akers Biosciences Dividends

Sorry No Data Available

Akers Biosciences Fundamentals

 31 Dec 2014 (USD)31 Dec 2015 (USD)31 Dec 2016 (USD)31 Dec 2017 (USD)
turnover4.43100.00%2.12100.00%2.96100.00%3.93100.00%m
pre tax profit-3.13-70.64%-9.58-453.00%-3.30-111.57%-5.81-147.74%m
attributable profit-3.14-70.99%-9.31-440.27%-3.30-111.36%-5.81-147.74%m
retained profit-3.14-70.99%-9.31-440.27%-3.30-111.36%-5.81-147.74%m
eps - basic-66.00 -181.00 -61.00 -61.00 
eps - diluted-66.00 -181.00 -61.00 -61.00 
dividends per share- - - - 

Akers Biosciences Balance Sheet

 31 Dec 2014 (USD)31 Dec 2015 (USD)31 Dec 2016 (USD)31 Dec 2017 (USD)
LSE:AKR:Liabilities+EQLSE:AKR:AssetsLSE:AKR:Liabilities+EQLSE:AKR:AssetsLSE:AKR:Liabilities+EQLSE:AKR:AssetsLSE:AKR:Liabilities+EQLSE:AKR:Assets
 31 Dec 2014 (USD)31 Dec 2015 (USD)31 Dec 2016 (USD)31 Dec 2017 (USD)
ASSETS
fixed assets fixed assets0.201.21%0.253.04%0.265.10%0.242.16%m
intangibles intangibles2.1813.07%1.4717.81%1.3025.60%1.1310.39%m
fixed investments fixed investments0.000.03%0.070.81%0.071.31%0.080.70%m
current assets - other current assets - other9.3756.29%4.2150.91%0.050.98%5.0146.03%m
stocks stocks0.915.44%1.1313.68%2.0440.05%1.8516.95%m
debtors debtors3.5421.23%0.748.90%1.3025.52%2.1519.75%m
cash & securities cash & securities0.462.74%0.404.86%0.071.43%0.444.03%m
TOTAL16.65100%8.27100%5.09100%10.89100%m
LIABILITIES
creditors - short creditors - short1.8411.07%1.6720.17%1.7033.38%1.7716.29%m
creditors - long creditors - long--%--%--%--%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL1.8411.07%1.6720.17%1.7033.38%1.7716.29%m
EQUITY
ord cap, reserves ord cap, reserves14.8188.93%6.6079.83%3.3966.62%9.1183.71%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL14.8188.93%6.6079.83%3.3966.62%9.1183.71%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Akers Biosciences Cash Flow Statement

31 Dec 2014 (USD)31 Dec 2015 (USD)31 Dec 2016 (USD)31 Dec 2017 (USD)
Operating CF-3.88-5.13-4.17-5.08m
Pre-Financing CF-13.17-0.05-0.33-10.10m
Retained CF0.35-0.05-0.330.37m

Akers Biosciences Brokers

NameActivityTypeMnemonicCode
Arbuthnot Securities LimitedMarket Maker(MMF)Broker/DealerARBTALESGB31MKT
Commerzbank AGMarket Maker(MMF)Broker/DealerKLWTDRESGB2LPST
Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Jefferies International LtdMarket Maker(MMF)Broker/DealerJEFFJEFFGB2X
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
LSE
AKR
Akers Bios..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191018 18:17:21